TITLE

Japan stem-cell trial stirs envy

AUTHOR(S)
Reardon, Sara; Cyranoski, David
PUB. DATE
September 2014
SOURCE
Nature;9/18/2014, Vol. 513 Issue 7518, p287
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya Yamanaka, director of the Center for iPS Cell Research and Applications at Kyoto University, Japan. Topics include the uses of iPS cells such as for correcting liver disease, retinal defects, and diabetes.
ACCESSION #
98525995

 

Related Articles

  • One Japan Stem Cell Institute Soars, One Struggles. Fox, Cynthia // Bioscience Technology;Jun2014, p1 

    The article reports on Center for iPS Cell Research and Application (CiRA) Nobel Prize winner and scientist Shinya Yamanaka in Japan. It mentions his statement over their proposed clinical trials on induced pluripotent stem cells (IPSCs). It also notes the problem of his sister institute, the...

  • Induced Pluripotent Stem Cells. Wilson, Kitchener D.; Wu, Joseph C. // JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613 

    The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption...

  • REWIND STEM CELLS, THEN FAST FORWARD. Coghlan, Andy // New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21 

    The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.

  • Stem-cell pioneer banks on future therapies. Cyranoski, David // Nature;8/9/2012, Vol. 488 Issue 7410, p139 

    The article focuses on the plans of Shinya Yamanaka of Kyoto University to build stem cell bank to be used for therapeutic purposes. It says that the scheme called the Induced Pluripotent Stem (iPS) Cell Stock, gained support from the country's health ministry committee. It mentions various...

  • THE CHANGING FACE OF THERAPEUTICS: AN INTRODUCTION TO STEM CELL AND REGENERATIVE THERAPIES. Seewoodhary, Jason // West London Medical Journal;Sep2011, Vol. 3 Issue 3, p28 

    Stem cell therapies are revolutionizing therapeutics by providing a curative approach to diseases for which, until very recently, symptomatic treatments were only available. This review will critically consider the multidisciplinary role, use and implications of embryonic, adult, and induced...

  • Adult Stem Cell Treatments Move Ahead, Embryonic Stem Cells Fall Farther Behind. Prentice, David A. // National Right to Life News;Summer2012, Vol. 39 Issue 3, p14 

    The article highlights induced pluripotent stem (iPS) cell treatment as a more effective and ethically viable method than embryonic stem cell treatment. It explains that iPS cells are made by adding a few genes to an adult cell, which allows it to act like an embryonic stem cell, removing the...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • Induced Pluripotent Stem Cells: Fundamentals and Applications of the Reprogramming Process and its Ramifications on Regenerative Medicine. Walia, Bhavita; Satija, Neeraj; Tripathi, Rajendra; Gangenahalli, Gurudutta // Stem Cell Reviews & Reports;Mar2012, Vol. 8 Issue 1, p100 

    Objective: To provide a comprehensive source of information about the reprogramming process and induced pluripotency. Background: The ability of stem cells to renew their own population and to differentiate into specialized cell types has always attracted researchers looking to exploit this...

  • Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Doulames, Vanessa M.; Plant, Giles W. // International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p530 

    Cervical-level injuries account for the majority of presented spinal cord injuries (SCIs) to date. Despite the increase in survival rates due to emergency medicine improvements, overall quality of life remains poor, with patients facing variable deficits in respiratory and motor function....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics